46.46.Z - Wholesale trade of pharmaceutical and medical products
10 - Manufacture of food products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
70 - Head office activities and management consultancy
73 - Advertising, market research and public relations
77 - Rental and leasing
96 - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | -0,3 | -0,5 | -70,9 |
EBITDA | 0,4 | -0,1 | -0,3 | -116,4 |
Short time liabilities | 0,4 | 1,5 | 1,5 | -3,1 |
Equity capital | 1,1 | 0,7 | 0,2 | -73,4 |
Operating profit (EBIT) | 0,3 | -0,2 | -0,4 | -107,7 |
Assets | 2,7 | 3,7 | 3,1 | -15,4 |
Net profit (loss) | 0,3 | -0,3 | -0,5 | -70,9 |
Cash | 0,1 | 0,1 | 0,1 | 65,7 |
Liabilities and provisions for liabilities | 1,6 | 3 | 2,9 | -1,6 |
Net income from sale | 1,9 | 3 | 2 | -32,8 |
Working assets | 2,7 | 1,6 | 1,2 | -30,3 |
Depreciation | 0 | 0 | 0,1 | 77,5 |
% | % | % | p.p. | |
Profitability of capital | 33,1 | -42,8 | -274,8 | -232 |
Equity capital to total assets | 39 | 19,2 | 6 | -13,2 |
Gross profit margin | 17,9 | -10 | -25,3 | -15,3 |
EBITDA Margin | 18,2 | -4,4 | -14,3 | -9,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 80 | 182 | 263 | 81 |
Current financial liquidity indicator | 1.6224958896636963 | 1.0835274457931519 | 0.779380738735199 | -0,3 |
Net dept to EBITDA | -0.17983873188495636 | -13.160879135131836 | -5.0181779861450195 | 8,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane